ProCE Banner Activity

Treatment Considerations Across the Bipolar Depression Spectrum

Podcast Episodes

Listen as 2 experts in psychiatry discuss treatment strategies across the spectrum of bipolar depression—including in patients with comorbidities and patients at risk of developing bipolar depression—as well as their thoughts regarding phase-specific vs holistic treatment approaches.

Released: October 06, 2022

Expiration: October 05, 2023

Share

Faculty

Vladimir Maletic

Vladimir Maletic, MD, MS

Clinical Professor of Psychiatry
University of South Carolina
Greenville, South Carolina

Greg W. Mattingly

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Intra Cellular Therapies

Faculty Disclosure

Primary Author

Vladimir Maletic, MD, MS

Clinical Professor of Psychiatry
University of South Carolina
Greenville, South Carolina

Vladimir Maletic, MD: consultant/advisor/speaker: AbbVie, Alfasigma, Alkermes, Intra-Cellular, Janssen, Lundbeck, Otsuka, Sage, Supernus.

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Greg W. Mattingly, MD: speaker: AbbVie, Alkermes, Corium, Eisai, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris Pharma; consultant: AbbVie, Acadia, Alkermes, Axsome, Corium, Eisai, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neos, Neurocrine, Noven, Otsuka, Redax, Rhodes, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, Teva, Tris Pharma; researcher: AbbVie, Acadia, Akili, Alkermes, Axsome, Boehringer, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, NLS-1 Pharma AG, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva.